BECKMAN COULTER, INC.

Manufacturer adverse-event records for BECKMAN COULTER, INC. come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 1999–2026 · heavy-book · quiet Death-code · injury-light

Death-code intensity

BECKMAN COULTER, INC. is quieter on Death-coded events

Death-coded event_type rows are 4 of 21,231 (0.02% · quiet tercile among 443 manufacturers). Absolute volume is heavy-book.

What the Death-code reading shows for BECKMAN COULTER, INC.

The standout signal for BECKMAN COULTER, INC. is Death-code intensity: 0.02% of 21,231 reports (quiet tercile), while absolute volume is heavy-book.

As a heavy-book manufacturer, portfolio size and reporting obligations inflate absolute counts - pair BECKMAN COULTER, INC. with device-family pages before treating company totals as a safety verdict. Event_type Death and Injury are one code per report; Patient Outcomes below use a separate FDA population.

Reports span 20 device types, led in this extract by Malfunction at 18,808 (88.6% of event_type total). Peak single-year volume reaches 11,683 reports across 26 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

21,231
Total Reports
4
Event-type Death
740
Injury Reports
20
Device Types

Event Types

Malfunction 18,808 (88.6%)
Other 1,668 (7.9%)
Injury 740 (3.5%)
11 (0.1%)
Death 4 (0.0%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

19,672 (92.3%)
Other 967 (4.5%)
Hospitalization 361 (1.7%)
Required Intervention 198 (0.9%)
R 67 (0.3%)
O 25 (0.1%)
Death 5 (0.0%)
L 4 (0.0%)
Congenital Anomaly 4 (0.0%)
Disability 4 (0.0%)
Life Threatening 3 (0.0%)
S 1 (0.0%)

Yearly Trend

99
1999: 15
00
2000: 6
01
2001: 20
02
2002: 62
03
2003: 145
04
2004: 172
05
2005: 297
06
2006: 390
07
2007: 419
08
2008: 606
09
2009: 105
10
2010: 580
11
2011: 11,683
12
2012: 5,830
13
2013: 187
15
2015: 3
16
2016: 4
17
2017: 3
18
2018: 30
19
2019: 1
21
2021: 2
22
2022: 2
23
2023: 9
24
2024: 187
25
2025: 433
26
2026: 40